The award recognizes Marie Heffern’s innovative research into the analytical characterization of peptide and protein therapeutics targeting incretin and related pathways, an emerging area critical to advancing treatments for diabetes and obesity.
New research led from UC Davis is part of a national consortium studying connections between Type 1 diabetes and cognitive decline in children. With a $2.5 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, this study builds on research on diabetic ketoacidosis in children.
